Insilico Medicine and Tenacia Biotechnology Collaborate for CNS Innovations Worth Up to $94.75 Million Insilico Medicine and Tenacia Biotechnology have expanded their partnership to enhance AI-driven CNS therapies, with potential deal value maxing at $94.75 million.

Insilico Medicine and Tenacia Biotechnology Collaborate for CNS Innovations Worth Up to $94.75 Million #United_States #Cambridge #Insilico_Medicine #CNS_therapies #Tenacia_Biotechnology